These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 36874510)

  • 41. Way to efficient microbial paclitaxel mass production.
    Li C; Qi Y; Sun Z; Jiang M; Li C
    Synth Syst Biotechnol; 2023 Dec; 8(4):673-681. PubMed ID: 37954482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Construction of Escherichia Coli Cell Factories for Production of Organic Acids and Alcohols.
    Liu P; Zhu X; Tan Z; Zhang X; Ma Y
    Adv Biochem Eng Biotechnol; 2016; 155():107-40. PubMed ID: 25577396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Designing Microbial Cell Factories for the Production of Chemicals.
    Cho JS; Kim GB; Eun H; Moon CW; Lee SY
    JACS Au; 2022 Aug; 2(8):1781-1799. PubMed ID: 36032533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Microbial synthesis of monoterpenoids: a review].
    Zhang F; Wang Y; Li C
    Sheng Wu Gong Cheng Xue Bao; 2022 Feb; 38(2):427-442. PubMed ID: 35234374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engineering plant metabolism into microbes: from systems biology to synthetic biology.
    Xu P; Bhan N; Koffas MA
    Curr Opin Biotechnol; 2013 Apr; 24(2):291-9. PubMed ID: 22985679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Yeast synthetic biology for high-value metabolites.
    Dai Z; Liu Y; Guo J; Huang L; Zhang X
    FEMS Yeast Res; 2015 Feb; 15(1):1-11. PubMed ID: 25047863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction of microbial consortia for microbial degradation of complex compounds.
    Cao Z; Yan W; Ding M; Yuan Y
    Front Bioeng Biotechnol; 2022; 10():1051233. PubMed ID: 36561050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetically encoded biosensors for microbial synthetic biology: From conceptual frameworks to practical applications.
    Yu W; Xu X; Jin K; Liu Y; Li J; Du G; Lv X; Liu L
    Biotechnol Adv; 2023; 62():108077. PubMed ID: 36502964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in engineering of microbial cell factories for intelligent pH regulation and tolerance.
    Gao X; Xu K; Ahmad N; Qin L; Li C
    Biotechnol J; 2021 Sep; 16(9):e2100151. PubMed ID: 34164941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Application of proteomics and metabolomics in microbial metabolic engineering].
    Yu W; Gao J; Zhou Y
    Se Pu; 2019 Aug; 37(8):798-805. PubMed ID: 31642249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. De novo biosynthetic pathways: rational design of microbial chemical factories.
    Prather KL; Martin CH
    Curr Opin Biotechnol; 2008 Oct; 19(5):468-74. PubMed ID: 18725289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Application of chronological lifespan in the construction of Escherichia coli cell factories].
    Liu J; Guo L; Luo Q; Chen X; Gao C; Song W; Liu L
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1277-1286. PubMed ID: 33973441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent advances in construction and regulation of yeast cell factories.
    Jiao X; Gu Y; Zhou P; Yu H; Ye L
    World J Microbiol Biotechnol; 2022 Feb; 38(4):57. PubMed ID: 35174424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and development of synthetic microbial platform cells for bioenergy.
    Lee SJ; Lee SJ; Lee DW
    Front Microbiol; 2013; 4():92. PubMed ID: 23626588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biotechnological potential and applications of microbial consortia.
    Qian X; Chen L; Sui Y; Chen C; Zhang W; Zhou J; Dong W; Jiang M; Xin F; Ochsenreither K
    Biotechnol Adv; 2020; 40():107500. PubMed ID: 31862233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction of stable microbial consortia for effective biochemical synthesis.
    Jiang Y; Wu R; Zhang W; Xin F; Jiang M
    Trends Biotechnol; 2023 Nov; 41(11):1430-1441. PubMed ID: 37330325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in stress-tolerance elements for microbial cell factories.
    Kuang Z; Yan X; Yuan Y; Wang R; Zhu H; Wang Y; Li J; Ye J; Yue H; Yang X
    Synth Syst Biotechnol; 2024 Dec; 9(4):793-808. PubMed ID: 39072145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Construction of synthetic microbial consortia for 2-keto-L-gulonic acid biosynthesis.
    Wang Y; Li H; Liu Y; Zhou M; Ding M; Yuan Y
    Synth Syst Biotechnol; 2022 Mar; 7(1):481-489. PubMed ID: 34977392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacterial genome reductions: Tools, applications, and challenges.
    LeBlanc N; Charles TC
    Front Genome Ed; 2022; 4():957289. PubMed ID: 36120530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ecological perspectives on synthetic biology: insights from microbial population biology.
    Escalante AE; Rebolleda-Gómez M; Benítez M; Travisano M
    Front Microbiol; 2015; 6():143. PubMed ID: 25767468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.